MAPT and Alzheimer disease: As reported (Hirata-Fukae et al., 2008), the pathologic hyperphosphorylation of tau detected by CP13, PHF1, and AT180 antibodies was found to be increased in the 3xTg-AD mice showing memory impairment (Figure 1H,I).